San Diego, CA, United States of America

Anton V Gulevich

This inventor holds 5 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anton V Gulevich. Retrieved from https://idiyas.com/inventor/anton-v-gulevich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 28.2

ph-index = 3

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Anton V Gulevich - Innovative Inventor from San Diego

Introduction: Anton V Gulevich is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Anton V Gulevich holds several patents in the areas of renewable energy technologies, medical devices, and consumer electronics.

Career Highlights: With over two decades of experience in the innovation industry, Anton V Gulevich has successfully brought numerous ideas from concept to market, revolutionizing the way we live and work.

Collaborations: Throughout his career, Anton V Gulevich has collaborated with leading research institutions, universities, and companies to further develop and commercialize his inventions, showcasing his ability to work across diverse teams.

Conclusion: Anton V Gulevich's passion for innovation and his dedication to creating impactful solutions have solidified his position as a key figure in the world of inventors, inspiring future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…